In general, PD-L1-positive TILs were reported in 85.9% of seminomas, 91% of embryonal carcinomas, 54.5% of choriocarcinomas, 60% of yolk sac tumors, and 35.7% of teratomas [60]. The gene discussed is CD274; the disease is seminoma.